moved:
Motion No. 12
That Bill C-9, in Schedule 1, be amended by replacing “amprenavir” and the dosage forms, the strengths and the routes of administration specified in that Schedule in relation to the product with the following:
“amprenavir tablet, 150 mg; capsule, 50 mg or 150 mg; oral solution, 15 mg/mL”
Motion No. 13
That Bill C-9, in Schedule 1, be amended by replacing “ceftriaxone” and the dosage forms, the strengths and the routes of administration specified in that Schedule in relation to the product with the following:
“ceftriaxone injection, 500 mg (as sodium); powder for injection, 250 mg (as sodium salt) in vial”
Motion No. 14
That Bill C-9, in Schedule 1, be amended by adding the following in alphbetical order:
“clarithromycin tablet, 500 mg; tablet extended release, 500 mg; powder for oral solution, 125 mg or 250 mg”
Motion No. 15
That Bill C-9, in Schedule 1, be amended by replacing “delavirdine” and the dosage forms, the strengths and the routes of administration specified in that Schedule in relation to the product with the following:
“delavirdine capsule or tablet, 100 mg (as mesylate)”
Motion No. 16
That Bill C-9, in Schedule 1, be amended by adding the following in alphabetical order:
“isoniazid + pyrazinamide + rifampin tablet, 50 mg + 300 mg + 120 mg”
Motion No. 17
That Bill C-9, in Schedule 1, be amended by replacing “lamivudine (3TC)” and the dosage forms, the strengths and the routes of administration specified in that Schedule in relation to the product with the following:
“lamivudine (3TC) capsule or tablet, 150 mg; oral solution 50 mg/5 mL”
Motion No. 18
That Bill C-9, in Schedule 1, be amended by adding the following in alphabetical order:
“moxifloxacin hydrochloride tablet, 400 mg; intravenous solution, 400 mg/250 mL”
Motion No. 19
That Bill C-9, in Schedule 1, be amended by replacing “zalcitabine” and the dosage forms, the strengths and the routes of administration specified in that Schedule in relation to the product with the following:
“zalcitabine capsule or tablet, 0.375 mg or 0.750 mg”
Motion No. 20
That Bill C-9, in Schedule 2, be amended by adding the following, in alphabetical order:
“Timor-Leste
Timor-Leste”